Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1

by Akamata, Kaname, Asano, Yoshihide, Aozasa, Naohiko, Noda, Shinji, Taniguchi, Takashi, Takahashi, Takehiro, Ichimura, Yohei, Toyama, Tetsuo, Sato, Shinichi
Published 2014

A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis

by Noda, Shinji, Asano, Yoshihide, Akamata, Kaname, Aozasa, Naohiko, Taniguchi, Takashi, Takahashi, Takehiro, Ichimura, Yohei, Toyama, Tetsuo, Sumida, Hayakazu, Yanaba, Koichi, Tada, Yayoi, Sugaya, Makoto, Kadono, Takafumi, Sato, Shinichi
Published 2012

Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis

by Noda, Shinji, Asano, Yoshihide, Nishimura, Satoshi, Taniguchi, Takashi, Fujiu, Katsuhito, Manabe, Ichiro, Nakamura, Kouki, Yamashita, Takashi, Saigusa, Ryosuke, Akamata, Kaname, Takahashi, Takehiro, Ichimura, Yohei, Toyama, Tetsuo, Tsuruta, Daisuke, Trojanowska, Maria, Nagai, Ryozo, Sato, Shinichi
Published 2014